摘要
目的:探讨参麦注射液的抗休克效果及其作用机制。方法:大鼠随机分为单纯失血性休克(HS)组、失血加脂多糖(HS+LPS)组、地塞米松(HS+LPS+Dex)组和参麦注射液(HS+LPS+SM)组。HS+LPS组大鼠模型复制:首先,大鼠放血至MAP40mmHg,维持10min(失血性休克),然后舌下静脉注射LPS(1·5mg/kg)。4h后留取肺脏组织,RT-PCR法测定IκBα和TLR4mRNA表达、ELISA法测TNF-α含量,并进行肺脏组织电镜观察。结果:HS+LPS+SM组TLR4mRNA表达明显低于HS+LPS组(P<0·05);HS+LPS+SM组IκBαmRNA表达明显高于HS+LPS组(P<0·05);HS+LPS+SM组肺脏组织匀浆TNF-α含量明显低于HS+LPS组(P<0·05);HS+LPS+SM组肺组织病理损伤显著轻于HS+LPS组。结论:参麦注射液能够下调肺脏组织中TLR4mRNA表达,同时上调IκBα的表达,进而抑制促炎介质TNF-α释放,提示参麦注射液可能通过调节NF-κB信号转导途径抑制炎症反应而对机体细胞起保护作用。
AIMM: To explore the molecular mechanism of anti - shock effect of Shenmai (SM) injection and to observe its influence on TLR4 and IκB mRNA expression in hemorrhagic shock (HS) plus LPS rat lung. METHODS: Rats were divided into HS, HS+ LPS, HS+ LPS+ dexamethasone (DEX), HS+ LPS+ SM group, respectively. HS+ LPS injury model of rats were induced by hemorrhagic shock ( MAP 40 mmHg for 10 min) followed by intravenous administration of lipopolysaccharide (LPS, 1.5 mg/kg). Four hours later, the TNF-α contents in lung tissue were measured by ELISA, TLR4 mRNA and IκBα mRNA expression were assayed by RT- PCR, ultrastructural changes of the type Ⅱ alveolar cell were observed by electron microscope. RESULTS: The TLR4 mRNA expression level in HS + LPS + SM group was significantly decreased as compared to HS + LPS group ( P 〈 0.05). Otherwise, the level of IκBα mRNA expression in HS +LPS + SM group was significantly increased as compared to HS + LPS group ( P 〈 0.05). The TNF - α content in lung tissue in HS + LPS + SM group was obviously lower than that in HS + LPS group ( P 〈0.05). In HS+ LPS+ SM group, the lung pathological injuries were alleviated as compared to HS+ LPS group. CONCLUSION: Shenmai injection down - regulates TLR4 mRNA expression and up- regulates IκBα mRNA expression in the lung, and inhibits the release of TNF - Iα in rots exposed to HS and LPS. These results suggest that Shenmai injection might have a protective effect on the tissue injured from hemorrhagic shock and endotoxic shock by regulating NF-κB signal transduction pathway and inhihiting pro- inflammatory cytokine production.
出处
《中国病理生理杂志》
CAS
CSCD
北大核心
2006年第4期730-733,共4页
Chinese Journal of Pathophysiology
基金
吉林大学创新基金资助项目(No.2003CX100)